News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Simply Wall St.113d agoneutral
Eli Lilly (LLY) Stock Looks Undervalued On Fair Value Yet Full On EarningsInvestor's Business Daily125d agobullish
Johnson & Johnson, IBD Stock Of The Day, In Buy Zone Heading Into EarningsSimply Wall St.127d agoneutral
Eli Lilly (LLY) Stock May Trade At A Cash Flow Discount But An Earnings PremiumInvestor's Business Daily135d agoneutral
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround OptimismInvestor's Business Daily149d agobullish
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up.Bloomberg153d agobullishVIDEO
Campbell's Earnings Beat; Eli Lilly Obesity Drug Results | Stock MoversStockStory153d agoneutral
Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)Medical Device Network171d agoneutral
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trendsSimply Wall St.177d agobullish
Eli Lilly (LLY) Valuation Check After Strong Q1 Guidance Upgrade And New Obesity Trial ResultsInsider Monkey185d agoneutral
Cantor Fitzgerald Lifts PT on Eli Lilly and Company (LLY) on Q1 Earnings CallSimply Wall St.185d agobullish
Novo Nordisk Guidance Lift Tests Valuation As Oral Wegovy Demand SurgesInsider Monkey185d agobullish
Eli Lilly (LLY) Reports Q1 2026 Revenue Surge of 56% Following FDA Approval of FoundayoSchaeffer's Investment Research186d agobullish
Signal: Eli Lilly Stock Remains a "Buy" After EarningsBarrons.com186d agoneutral
Novo Stock Rises After Earnings. It’s Taking the Weight-Loss Drug Fight to Eli Lilly.Simply Wall St.189d agobullish
Results: Eli Lilly and Company Beat Earnings Expectations And Analysts Now Have New Forecasts